alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### EPA SANITIZED

STRUCTURE ACTIVITY TEAM REPORT 07/20/07

CASE NUMBER: P07-0553

RELATED CASES:

CONCLUSIONS/DISCUSSIONS

TYPE OF CONCERN: HEALTH ECOTOX

LEVEL OF CONCERN: 1-2 1

KEYWORDS: LUNG OVERLOAD

SUMMARY OF ASSESSMENT

FATE: Solid S < 0.001 mg/L at 25 E C (E)

VP < 1.0E-6 torr at 25 E C (E)

BP > 400 E C (E)
H < 1.00E-8 (E) POTW removal (%) = 90 via sorption Time for complete ultimate aerobic biodeg > mo Sorption to soils/sediments = v.strong

PBT Potential: P3B1T1 *CEB FATE: Migration to ground water = negl

HEALTH: Absorption is nil all routes (pchem). Concern for lung toxicity if inhaled based on lung overload for poorly soluble particles (D50 = 1 - 2 μ m; D90 = 5 - 6.5 μ m).

*CEB HEALTH: Low moderate concern (Inhalation)

ECOTOX: Predicted (P) toxicity values in mg/L (ppm) are:

fish 96-h LC50 = * P daphnid 48-h LC50 = * P green algal 96-h EC50 = * P fish Chronic Value (ChV) = * P daphnid ChV = * P algal ChV = * P based on SARs for surface-treated ; SAR chemical class = particle - ; NavgMW >100,000 with 0% < 1000; hardness <150.0 mg/L as CaCO3, ECs based on 100% active ingredients and nominal concentrations, and TOC <2.0 mg/L; low concern for toxicity;

assessment factor = 10.0 concern concentration (CC) = * mg/L

*CEB ECOTOX: No releases to water

SAT Co-chair: Leonard Keifer 564-8916
**Exhibit 10.14**

**Director Compensation Arrangement**

Effective January 1, 2006, Hub International Limited’s directors receive annual equitycompensation in the form of restricted share units equal to $25,000 in addition to compensation in the form of an annual retainer of $25,000, $1,000 per major Board or Committee meeting attended and $500 per minor Board or Committee meeting attended(the classification of the meeting to be determined jointly by the Chair of the Compensation Committee and the Chair of the Board, having regard to preparation time, meeting time and whether a significant decision or vote was required). In addition,the Audit Committee Chairperson receives an additional retainer of $10,000 (to be paid in cash or common shares); the Compensation Committee Chairperson receives an additional retainer of $5,000 (to be paid in cash or common shares); and theNominating and Corporate Governance Committee Chairperson receives an additional retainer of $5,000 (to be paid in cash or common shares). Hub International Limited’s directors are reimbursed for travel and other out-of-pocket expenses incurredin attending Board or committee meetings or in otherwise being engaged in our business.
HomeNRC LibraryDocument CollectionsNews Releases1997

# NRC to Accept Public Comments at October 27 Meeting Regarding Decommissioning of Haddam Neck Nuclear Power Plant

----

----

I-97-136

October 16, 1997

NRC TO ACCEPT PUBLIC COMMENTS AT OCTOBER 27 MEETING REGARDING DECOMMISSIONING OF HADDAM NECK NUCLEAR POWER PLANT

Nuclear Regulatory Commission officials will solicit comments from the public regarding decommissioning plans for the Haddam Neck nuclear power plant on Monday, October 27, at Haddam Killingsworth High School. The meeting will be held from 6:30 to 10 p.m. in the auditorium at the school, located in Higganum, Conn.

Last December, owner Northeast Utilities announced that it was permanently closing the Haddam, Conn., plant. In August, in accordance with NRC regulations, the utility submitted a Post-Shutdown Decommissioning Activities Report to the agency, outlining its plans for terminating the facility and cleaning up the site.

NU has chosen the DECON option, which is expected to result in the decontamination and/or dismantlement of the majority of plant structures and facilities by 2004.

At the meeting, the NRC will do the following: describe the utility's planned activities; describe the regulatory process for decommissioning; receive public comments regarding health and safety issues and the protection of the environment during decommissioning; and provide an opportunity for state and local representatives to participate. In addition, the utility will discuss its plans for decommissioning the plant.

The meeting will be transcribed by a court reporter.

Page Last Reviewed/Updated Thursday, March 25, 2021
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<PAGE>

                                   EXHIBIT 27

                            STAR GAS PARTNERS, L.P.



THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM STAR GAS
PARTNERS, L.P. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF
MARCH 31, 2001 AND CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THE
INTERIM PERIOD OCTOBER 1, 2000 THROUGH MARCH 31, 2001 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.


MULTIPLIER                                                  1,000
NAME                                      STAR GAS PARTNERS, L.P.
CIK                                                    0001002590
PERIOD START                                          OCT-01-2000
PERIOD TYPE                                                 6-MOS
FISCAL-YEAR-END                                      SEPT-30-2001
PERIOD-END                                            MAR-31-2001
CASH                                                       16,908
SECURITIES                                                      0
RECEIVABLES                                               205,490
ALLOWANCES                                                  5,648
INVENTORY                                                  26,001
CURRENT-ASSETS                                            261,088
PP&E                                                      247,891
DEPRECIATION                                               45,729
TOTAL-ASSETS                                              804,439
CURRENT LIABILITIES                                       207,030
BONDS                                                     335,198
PREFERRED-MANDATORY                                             0
PREFERRED                                                       0
COMMON                                                    257,795
OTHER-SE                                                        0
TOTAL LIABILITY-AND-EQUITY                                804,439
SALES                                                     730,314
TOTAL-REVENUES                                            793,951
CGS                                                       475,915
TOTAL-COSTS                                               549,272
OTHER-EXPENSE                                             141,851
LOSS-PROVISION                                              3,747
INTEREST EXPENSE                                           17,120
INCOME-PRETAX                                              81,961
INCOME-TAX                                                  1,639
INCOME-CONTINUING                                          80,322
DISCONTINUED                                                    0
EXTRAORDINARY                                                   0
CHANGES                                                     1,466
NET INCOME                                                 81,788
EPS-PRIMARY                                                  3.83
EPS-DILUTED                                                  3.81

</TABLE>
Exhibit 10.2






Exhibit 10.2




AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE




THIS AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this “Amendment”) is entered into as
of January 14, 2011 by and among BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.P. (“Investor”) and
VIA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”). Investor and the Company are
sometimes referred to in this Amendment, individually, as a “Party” and, collectively, as the
“Parties.”




	1.	 	Amendment of Note. The Parties hereby agree to amend that certain Promissory Note,
dated March 26, 2010, made and issued by the Company to Investor under that certain Note and
Warrant Purchase Agreement dated as of March 26, 2010, which Promissory Notes were amended and
restated on November 15, 2010 (as amended, restated, supplemented or otherwise modified from
time to time, the “Note”), as follows: the phrase “December 31, 2010” in subclause (i) of
Section 4 of the Note is hereby deleted in its entirety and replaced with “June 30, 2011.”






	2.	 	Survival. Except as expressly modified hereby, all of the provisions of the Note
remain in full force and effect and shall be unaffected by this Amendment.






	3.	 	Execution in Counterparts. This Amendment may be executed in one or more
counterparts, each of which shall be deemed an original but all of which together will
constitute one and the same instrument. This Amendment or any counterpart may be executed and
delivered by facsimile or email with scan attachment copies or pdf, each of which shall be
deemed an original.





[Signature Page Follows]



 












 





IN WITNESS WHEREOF, the Parties have executed this Amendment as of the date first above
written.



	 	 	 	 	 	 	 
	 	 	COMPANY:	 	 
	 
	 	 	 	 	 	 
	 	 	VIA PHARMACEUTICALS, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Karen S. Wright
 

Name: Karen S. Wright
	 	 
	 

	 	 	 	Title: VP Finance, Controller	 	 
	 
	 	 	 	 	 	 
	 	 	Address:	 	 
	 
	 	 	 	 	 	 
	 	 	VIA Pharmaceuticals, Inc.	 	 
	 	 	750 Battery Street, Suite 330	 	 
	 	 	San Francisco, California 94111	 	 
	 	 	Attention: Vice President, Controller	 	 
	 	 	Facsimile: (415) 283-2214	 	 
	 	 	Electronic mail:	 	 
	 	 	Karen.Wright@viapharmaceuticals.com	 	 






[Signature page to Note Amendment]



 


 









 





	 	 	 	 	 	 	 	 	 
	 	 	INVESTOR:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.P.,	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Bay City Capital Management IV LLC, its general partner	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Bay City Capital LLC, its manager	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Fred Craves	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:
	 	Fred Craves	 	 
	 

	 	 	 	Title:
	 	Managing Director 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	Address:



Bay City Capital Fund IV, L.P.	 	 
	 	 	750 Battery Street, Suite 400	 	 
	 	 	San Francisco, California 94111	 	 
	 	 	Attention: Managing Director	 	 
	 	 	Facsimile:	 	 
	 	 	Electronic mail:	 	 






[Signature page to Note Amendment]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-2000
<CASH>                                           7,948
<SECURITIES>                                       544
<RECEIVABLES>                                   39,347
<ALLOWANCES>                                     1,000
<INVENTORY>                                     39,456
<CURRENT-ASSETS>                                90,574
<PP&E>                                         229,447
<DEPRECIATION>                                  32,756
<TOTAL-ASSETS>                                 478,063
<CURRENT-LIABILITIES>                           45,912
<BONDS>                                        260,743
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     107,498
<TOTAL-LIABILITY-AND-EQUITY>                   478,063
<SALES>                                        121,861
<TOTAL-REVENUES>                               121,861
<CGS>                                           91,441
<TOTAL-COSTS>                                   91,441
<OTHER-EXPENSES>                                   147
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              14,169
<INCOME-PRETAX>                                  7,604
<INCOME-TAX>                                     3,873
<INCOME-CONTINUING>                              3,731
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,731
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
HomeNRC LibraryDocument CollectionsManagement Directives

# Volume 11 - Procurement

 

*This page includes links to files in non-HTML format. See Plugins, Viewers, and Other Tools for more information.*

 

Page Last Reviewed/Updated Thursday, August 4, 2022

Section Navigation

#### Navigation

          - Volume 1
          - Volume 2
          - Volume 3
          - Volume 4
          - Volume 5
          - Volume 6
          - Volume 7
          - Volume 8
          - Volume 9
          - Volume 10
          - Volume 11
          - Volume 12
          - Volume 13
          - Volume 14

#### Spotlight

#### Choose a Section

                - The Commission
                - License Renewal Generic Environmental Review
                - Job Openings
                - Palisades Restart
                - Environmental Justice 
                - Pilgrim Water Releases
                - Monticello Tritium Issue
                - International Strategy 2021-2025
                - Tribal Liaison Program
                - MAP-X
                - Transformation at the NRC - Updated
                - OIG Hotline
                - Rulemaking Activity
                - Commission Documents
                - Advanced Reactors
                - Nuclear Security
                - Strategic Plan

Page Last Reviewed/Updated Thursday, August 4, 2022
HomeNRC LibraryDocument CollectionsNews Releases1999

# GPU to Update NRC on Oyster Creek Decommissioning Planning

----

----

I-99-21 March 24, 1999

 

**GPU TO UPDATE NRC ON OYSTER CREEK DECOMMISSIONING PLANNING**

Representatives of GPU Nuclear Inc. will update Nuclear Regulatory Commission staff on Monday, March 29, regarding planning for the possible permanent shutdown of the Oyster Creek nuclear power plant. GPU owns and operates Oyster Creek, a boiling-water reactor located in Lacey Township, N.J.

The meeting will begin at 10 a.m. in the board room of the plant's administration building, located on Route 9. It will be open to the public.

GPU is currently trying to find a buyer for the facility. In the meantime, the company is continuing to plan for the possible decommissioning of the 29-year-old plant. Last year, after a previous attempt to sell the plant was unsuccessful, GPU said it planned to either shut down Oyster Creek in late 2000 or operate it until the expiration of its NRC license in December 2009.

Page Last Reviewed/Updated Thursday, March 25, 2021
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1473 Introduced in House (IH)]

<DOC>

115th CONGRESS
  1st Session
                                H. R. 1473

To prohibit the deployment of members of the Armed Forces to Syria for 
    purposes of engaging in ground combat operations, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 9, 2017

 Ms. Lee (for herself, Mr. Jones, Mr. Capuano, Mr. Huffman, Mr. Pocan, 
    Mr. Pallone, Mr. McGovern, Mr. Lewis of Georgia, Ms. Fudge, Mr. 
 Butterfield, Mr. Cleaver, Mr. DeSaulnier, Ms. Bass, Mr. Hastings, Ms. 
 Moore, Mr. Raskin, and Ms. Velazquez) introduced the following bill; 
         which was referred to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
To prohibit the deployment of members of the Armed Forces to Syria for 
    purposes of engaging in ground combat operations, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Prohibit Expansion of U.S. Combat 
Troops into Syria Act''.

SEC. 2. PROHIBITION ON UNITED STATES GROUND COMBAT PRESENCE IN SYRIA.

    (a) Prohibition.--Except as provided in subsection (b), no funds 
authorized to be appropriated or otherwise made available for the 
Department of Defense may be obligated or expended for the purpose of--
            (1) deploying members of the United States Armed Forces on 
        to the ground of Syria for the purposes of engaging in ground 
        combat operations;
            (2) awarding a contract to a private security contractor to 
        conduct any activity on the ground of Syria; or
            (3) otherwise establishing or maintaining any presence of 
        members of the United States Armed Forces or private security 
        contractors on the ground of Syria, unless the purpose of such 
        presence is limited solely to rescuing or protecting members of 
        the United States Armed Forces from imminent danger.
    (b) Exception.--The prohibition under subsection (a) does not apply 
to the deployment of United States Armed Forces to protect, rescue, or 
remove United States personnel.
                                 <all>
```
HomeNRC LibraryDocument CollectionsInspection ManualChange Notices1998

# Change Notice 98-015

Issue Date: 09/28/1998

IM001

NRC INSPECTION MANUAL PIPB

 

 

----

 

*This page includes links to files in non-HTML format. See Plugins, Viewers, and Other Tools for more information.*

 

END

Page Last Reviewed/Updated Friday, April 17, 2020
No. 91-696.

#### Wilson *v.*Security Insurance Co.

Sup. Ct. Conn. Certiorari denied.
EXHIBIT 32.2

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Annual  Report  of  Galaxy  Energy  Corporation  (the
"Company") on Form 10-KSB for the period ending November 30, 2003, as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Carmen Lotito, Chief Financial Officer of the Company,  certify,  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that:

(1)      The Report fully  complies  with the  requirements  of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

(2)      The  information  contained  in  the  Report  fairly  presents,  in all
         material respects, the financial condition and results of operations of
         the Company.


/s/ CARMEN J. LOTITO
-------------------------------------------
Carmen J. Lotito
Chief Financial Officer
<PAGE>


CINGULAR WIRELESS LLC
EXHIBITS

                                                                    EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Annual Report of Cingular Wireless LLC (the
"Company") on Form 10-K for the year ended December 31, 2004 as filed with the
Securities and Exchange Commission (the "Report"), I, Peter A. Ritcher, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to
the best of my knowledge:

         (1)   The Report fully complies with the requirements of Section 13(a)
               of the Securities Exchange Act of 1934; and

         (2)   The information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.






                                        By:  /s/ Peter A. Ritcher
                                           -------------------------------------
                                           Peter A. Ritcher
                                           Chief Financial Officer
                                           Date: March 7, 2005
<PAGE>

                                                                      Exhibit 32

                                 CERTIFICATIONS OF
                CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                        PURSUANT TO 18 U.S.C. SECTION 1350,
                              AS ADOPTED PURSUANT TO
                   SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of CancerVax Corporation (the
"Company") on Form 10-K for the period ended December 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, David
F. Hale, President and Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), of
the Securities Exchange Act of 1934; and

2. That information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

     Date: March 15, 2005

                                                        /s/ David F. Hale
                                                --------------------------------
                                                           David F. Hale
                                                   President and Chief Executive
                                                              Officer

     In connection with the Annual Report of CancerVax Corporation (the
"Company") on Form 10-K for the period ended December 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, William
R. LaRue, Senior Vice President and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), of
the Securities Exchange Act of 1934; and

2. That information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

     Date: March 15, 2005

                                                     /s/ William R. LaRue
                                                --------------------------------
                                                        William R. LaRue
                                                 Senior Vice President and Chief
                                                        Financial Officer